An antisense oligonucleotide targeting the αV integrin gene inhibits adhesion and induces apoptosis in breast cancer cells
- 29 February 2000
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 36 (3) , 397-409
- https://doi.org/10.1016/s0959-8049(99)00275-0
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Antisense oligonucleotide therapeuticsExpert Opinion on Investigational Drugs, 1999
- Conformational Preorganization, Hydration, and Nucleic Acid Duplex StabilityAntisense and Nucleic Acid Drug Development, 1998
- The integrin β subunitThe International Journal of Biochemistry & Cell Biology, 1998
- Controversies in the Cellular Pharmacology of OligodeoxynucleotidesAntisense and Nucleic Acid Drug Development, 1997
- Human breast cancer induces osteoclast activation and increases the number of osteoclasts at sites of tumor osteolysisJournal of Orthopaedic Research, 1996
- Coordinated expression of the vitronectin receptor and the urokinase-type plasminogen activator receptor in metastatic melanoma cells.Journal of Clinical Investigation, 1995
- Antisense oligodeoxynucleotidesCurrent Opinion in Oncology, 1994
- Integrins: Versatility, modulation, and signaling in cell adhesionCell, 1992
- Comparison of cDNA-derived protein sequences of the human fibronectin and vitronectin receptor .alpha.-subunits and platelet glycoprotein IIbBiochemistry, 1987
- Integrins: A family of cell surface receptorsCell, 1987